A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy

Abstract

In this large prospective study, the rate of SRs was low, thus confirming that injection immunotherapy has an acceptable risk/benefit ratio when prescribed and carried out according to recommendations.